← All trials
NCT00221039
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2004
- Primary completion
- Feb 1, 2009
- Completion date
- Feb 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 19
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- MallinckrodtLead sponsor
- University of PittsburghCollaborator
- Case Western Reserve UniversityCollaborator
- Vanderbilt UniversityCollaborator
- Rush UniversityCollaborator
- University of MinnesotaCollaborator
- Boston UniversityCollaborator
- University of Texas at HoustonOverall official - principal investigator
- University of Texas at HoustonCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.